Ketamine for Prehosptial Use: What Took So Long? · Ketamine for Prehosptial Use: What Took So...

33
Ketamine for Prehosptial Use: What Took So Long? Christopher Galton, MD NRP FP - C

Transcript of Ketamine for Prehosptial Use: What Took So Long? · Ketamine for Prehosptial Use: What Took So...

Ketamine for Prehosptial Use:

What Took So Long?

Christopher Galton, MD NRP FP-C

Disclosures

I have no financial disclosures

Ketamine is cheap!

The only bad question . . .

Objectives

Highlight the history of ketamine

Discuss the pharmacodynamics

Discuss the kinetics

Assess the value in EMS

Discuss ketamine in our standards

Determine appropriate patient groups

Your Name

Paramedic

Opening on my Soap Box

In the Beginning

Developed by Calvin Stevens in 1962

Trying to improve or replace PCP

First human use on prisoners in 1964

Broad application in Vietnam

Psychiatry research

in the 1970s

All good intentions …

Non-medical use exploded in the 1990s

Began appearing at raves

Also associated with date rape

Schedule III classification assigned 1999

WHO - List of Essential Medications

Pharmacodynamics

NMDA receptor antagonist

Believed to have AMPA agonist activity

Weak µ and K opioid agonists

D2 agonist activity

Inhibits reuptake of neurotansmitters:

Serotin, dopamine, and norepinephrine

Pharmacodynamics

Truthfully . . . we don’t really

know why it works

CNS Pharmacodynamics

Anesthetic

Amnestic

Dissociation

Hallucinogenic

Euphoria

Antidepressant

Analgseic

Interferes with pain

transmission in the

spinal cord

Inhibits nitric oxide

synthase

PNS Pharmacodynamics

Catecholamine

Reuptake is inhibited

Serotonin reuptake inhibition in GI tract

Nausea and vomiting

ß2 adrenergic reception

Bronchodilation

What does all that mean?

Provides potent pain relief

Very good agent for sedation

Moderately good amnestic agent

Moderately good bronchodilator

Pharmacokinetics

Water and lipid soluble

Administration routes include:

IV (100%)

IM (90%)Oral (15-20%)

Topical

IN (25-50%)

SL (30%)

Rectal (30%)

Pharmacokinetics

Onset time

IV - 30 seconds

IM - 3-4 minutes

IN - 5-10 minutes

PO - 30 minutes

Pharmacokinetics

Duration

Analgesic

IV duration 1-2 hours

IM duration 3-4 hours

Anesthetic

IV duration 5-10 min

IM duration 10-20 min

Metabolized by liver into norketamine

Administration Details

Schedule III controlled substance

Stored at room temperature

Available in following concentrations:

10 mg/mL (20 mL)- $ 20 (IV, analgesia)

50 mg/mL (10 mL) - $ 5 (IV, analgesia, RSI)

100 mg/mL (5 mL) - $ 10 (IM, restraint, RSI)

Lexicomp Online, Adult Lexi-Drugs Online, Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc.; 2017; 10 May 2017

Administration Details

No renal adjustments

No hepatic adjustments

Compatible with our formularies

No known problems with pregnancy

Crosses the placenta

Laryngeal reflexes remain intact

Ketamine Contraindications

Hypersensitivity

If hypertension could be hazardous

Suspicion of symptomatic aortic aneurysm

Known cerebral AVM with hypertension

Known intracranial hemorrhage with

compensatory hypertension

Ketamine Side Effects

Induces a dissociative state

Emergence reactions Occurs in 10% of patients

Typically presents with mild agitation

Secretions

Nausea and vomiting

Nystagmus

Ketamine Side Effects

Ketamine (Ketalar) increases MAP

Understand the equations

CPP = MAP – ICP

Brain perfusion is adequate

Increased IOP

Wang, Xin; Ding, Xibing; Tong, Yao; et al. "Ketamine does not increase intracranial pressure compared with opioids: meta-analysis of randomized controlled trials". Journal of Anesthesia. May 2014. 28: 7.

Ketamine Side Effects

Sympathomimetic effects

Direct myocardial depression

Bronchodilation

Lowers seizure threshold

Increases cerebral metabolism

Increases cerebral blood flow

Tonic-clonic movements

Ketamine Dosing

Induction of Anesthesia

IV dosing at 2-4 mg/kg

IM dosing at 4-10 mg/kg

Dissociation

IV dosing at 1-2 mg/kg

IM dosing at 2-4 mg/kg

Ketamine Dosing

Sedation

IV dosing at 0.1 to 0.5 mg/min

IV infusion at 15-30 mcg/kg/min

Pain

IV dosing at 0.1-0.2 mg/kg

IV infusion at 5-10 mcg/kg/min

IN dosing at 0.5-1 mg/kg

What does this mean for EMS?

Provides potent pain relief

Very good sedating agent

Moderately good bronchodilator

Moderately good amnestic agent

Which patients?

Analgesia

Chemical restraint

Sedation

Induction

Analgesia

Standard EMS analgesic

Best if used synergistically with opioids

Safe for just about all patients

Analgesic

Reduced post-operative

nausea/vomiting

Reduce wind-up phenomena

Reduce spinal sensitization

Low doses have few psych side effects

Bell, RF; Dahl, JB; Moore, RA; et al. Perioperative ketamine for acute postoperative

pain". Pain, Palliative and Supportive Care Group. Cochrane Database of Systematic Reviews (1): 25 January 2006.

Chemical Restraint

Excited delirium

Dosing

250 mg IM

0.5-1 mg/kg IV

Faster than

haloperidol

Concern for intubation in the ED?

Sedation

Ketamine

IV versus IM

Re-dose as needed . . .

RSI

Multi-systems trauma Safe when used correctly

Facilitated extraction

Procedures

Induction

Agent of choice for DSI

Primary RSI induction agent

Terrible facilitation agent

Stability is all related to the adrenals

Bronchodilation

Asthma exacerbation

COPD exacerbation

Not a first line agent

May work synergistically due to sedation

Dosing is difficult to determine

Reactive airway disease

Increased secretions

Amnesia

Not the best amnestic agent

Not the choice for amnesia alone

1 mg/kg/hr infusion is fairly consistent

Property exploited by recreational use

Every kiss begins with “K”

[email protected]

Thank you for your time . . .